Oncogene-addicted metastatic non-small-cell lung cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
Maastricht University · Aberdeen Royal Infirmary · +15 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
766
total citations
- FWCI
- 184.49
- Percentile
- 100%
- References
- 104
Citations per year
Authors
12Topics & keywords
Topics
Keywords
- Medicine
- Guideline
- Oncology
- Lung cancer
- Cancer
- Clinical Practice
- Internal medicine
- Chemotherapy
No related works found for this paper.
Funding
- AAmgen
- ELEli Lilly and Company
- PPfizer
- AAstraZeneca
- SSanofi
- GSGilead Sciences
- IAInternational Association for the Study of Lung Cancer
- ASAmerican Society of Clinical Oncology
- TPTaiho Pharmaceutical
- VPVertex Pharmaceuticals
- COClovis Oncology
- MTMirati Therapeutics
- BBeiGene
- IIncyte
- YYuhan
- LLunit
- GTG1 Therapeutics
- EEisai
- DKDeutsche Krebshilfe
- ESEuropean Society for Medical Oncology
- CSChinese Society of Clinical Oncology
- HKHong Kong Cancer Fund
- IIpsen
- DVDa Volterra
- GGenentech
- IIgnyta
- LOLoxo Oncology
- DSDaiichi Sankyo Europe